Clinical Predictors of Nephritis in Systemic Lupus Erythematosus

Annals of the Academy of Medicine Singapore

Volumn 27, Issue 1, 1998, Pages 16-20

  Thumboo, J ^a   Fong, K Y ^a   Chia, H P ^b   Chng, H H ^a   Koh, E T ^a   Leong, K H ^a   Koh, W H ^a   Howe, H S ^a   Leong, K P ^a   Boey, M L ^a   Feng, P H ^a  

^a TAN TOCK SENG HOSPITAL   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Asia; Hypertension; Leukopaenia; Risk factors; Thrombocytopaenia

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; COHORT ANALYSIS; CONFIDENCE INTERVAL; FEMALE; HUMAN; HYPERTENSION; INCIDENCE; LEUKOPENIA; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; MIDDLE AGED; PREDICTION AND FORECASTING; PROPORTIONAL HAZARDS MODEL; PROTEINURIA; REGISTER; RETROSPECTIVE STUDY; RISK FACTOR; SEX RATIO; SINGAPORE; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIA;

ADULT; AGE DISTRIBUTION; COHORT STUDIES; CONFIDENCE INTERVALS; FEMALE; HUMANS; HYPERTENSION; INCIDENCE; LEUKOPENIA; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; PROTEINURIA; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; SEX DISTRIBUTION; SINGAPORE; THROMBOCYTOPENIA;

EID: 0031617296     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Wallace D J. Prognostic subsets and mortality in systemic lupus erythematosus. In: Wallace D J, Hahn B H, editors Dubouis Lupus Erythematosus. Philadelphia: Lea and Febiger, 1994:606-15.
2. Balow J E, Boumpas D T, Fessler B J, Austin III H A. Management of lupus nephritis Kidney Int 1996; 49(Suppl 53):588-92.
3. Donadio J V, Glassock R J. Immunosuppressive therapy in lupus nephritis. Am J Kidney Dis 1993; 21:239-50
4. Tan E M, Cohen A S, Fries J F, Masi A T, McShane D J, Rothfield N F, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25:1271-7.
5. Williams G H Hypertensive vascular disease. In: Wilson JE, Braunwald E, Isselbacher K J, Petersdorf R G, Martin J B, Fauci A S, et al, editors. Harrison's Principles of Internal Medicine. New York: McGraw-Hill, 1991:1001-15.
6. Alberti K G M M, Hockday TDR Diabetes Mellitus. In: Weatherall D J, Ledingham J G G, Warrell D A, editors Oxford Textbook of Medicine. London: Oxford Univ Press, 1983:9.5-9.49.
7. Tucker L B, Menon S, Isenberg DA.Systemic lupus in children: daughter of the Hydra? Lupus 1995; 4:83-5.
8. Petri M, Perez-Gutthann S, Longenecker J C, Hochberg M Morbidity of systemic lupus erythematosus: role of race and socio-ceconomic status. Am J Med 1991; 91:345-53.
9. Belmont H M, Abramsom S B, Lie J T. Pathology and pathogenesis of vascular injury in systemic lupus erythematosus. Arthritis Rheum 1996; 39:9-22
10. Tolins J P, Schultz P, Raij L Mechanisms of hypertensive glomerular injury. Am J Cardiol 1988; 62:54G-58G
11. Raij L, Azar S, Keane W Mesangial immune injury, hypertension and progressive glomerular damage in Dahl rats. Kidney Int 1984; 26:137-43
12. Schmid M, Meyer S, Wegner R, Ritz E. Increased risk of hypertension in glomerulonephritis. J Hypertens 1990; 8:573-7.
13. Krolewski A S, Canessa M, Warram J H, Laffel LM, Christlieb A R, Knowler W C, et al. Predisposition to hypertension and susceptibility to renal disease in insulin-dependant diabetes mellitus N Engl J Med 1988; 318:40-5.
14. Font J, Torras A, Cervera R, Darnell A, Rervert L, Ingelmo M. Silent renal disease in systemic lupus erythematosus. Clin Nephrol 1987; 27:283-8.
15. Rambausek M, Fliser D, Ritz E. Albuminuria of hypertensive patients. Clin Nephrol 1992; 38(Suppl 1) S40-5
16. Ritz E, Nowicki M, Fliser D, Horner D, Klimm H-P Proteinuria and hypertension Kidney Int 1994, 46(Suppl 47):S76-S80.
17. Quismono F P. Cardiac abnormalities in systemic lupus erythematosus. In. Wallace D J, Hahn B H, editors. Dubouis Lupus Erythematosus. Philadelphia: Lea and Febiger, 1994:606-15.
18. Lawrence J, Wong J E L, Nachman R. The cellular haematology of systemic lupus erythematosus. In: Lahita R G, editor. Systemic Lupus Erythematosus. New York: Churchill Livingstone, 1992:782.
19. Luscher T F. The endothelium in hypertension: bystander, target or mediator? J Hypertens 1994; 12(Suppl 10):S105-S116.
20. Peterson J C, Adler S, Burkart J M, Greene T, Hebert L A, Hunsicker L G, et al. Blood pressure control, proteinuria and the progression of renal disease Ann Intern Med 1995; 123:754-62.
21. Freedman B I, Spray B J, Heise E R, Espeland M A, Canzanello V J. A racecontrolled human leucocyte antigen frequency analysis in lupus nephritis. Am J Kidney Dis 1993;21:378-82.
22. Studenski S, Allen N B, Caldwell D S, Raice J R, Polisson R P. Survival in systemic lupus erythematosus. Arthritis Rheum 1987; 30:1326-32.
23. Koh E T, Boey M L. Late onset lupus: A clinical and immunological study in a predominantly Chinese population. J Rheumatol 1994; 21:1463-7.
24. Harlrey J B, Gaither K K. Autoantibodies. Rheum Dis Clin North Am 1988; 14:43-56.
25. Homma M, Mimori T, Takeda Y, Akama H, Yoshida T, Ogasawara T, et al. Autoantibodies to the Sm antigen: Immunological approach to clinical aspects of systemic lupus erythematosus. J Rheumatol 1987; 14(Suppl 13):188-93
26. Maddison P J, Isenberg D A, Goulding N J, Leddy J, Skinner R P. Anti La (SSB) identifies a distinctive subgroup of systemic lupus erythematosus. Br J Rheumatol 1988; 27:27-31.
27. Sasaki T, Muryoi T, Hatakeyama A, Suzuki M, Sato H, Seino J, et al. Circulating anti-DNA immune complexes in active lupus nephritis. Am J Med 1991; 91:355-62.
28. Hochberg M C, Boyd R E, Ahearn J M, Arnett F C, Bias W B, Provost T T, et al. Systemic lupus erythematosus: a review of clinico-laboratory features and immunologic markers in 150 patients with emphasis on demographic subsets. Medicine 1985; 64:285-95.